Comparison of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction Among Those With Versus Without Diabetes Mellitus

被引:85
|
作者
Aguilar, David [1 ,2 ,3 ]
Deswal, Anita [1 ,2 ,3 ,4 ]
Ramasubbu, Kumudha [1 ,2 ,3 ]
Mann, Douglas L. [5 ]
Bozkurt, Biykem [1 ,2 ,3 ]
机构
[1] Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
[3] Michael E DeBakey VA Med Ctr, Cardiol Sect, Houston, TX USA
[4] Michael E DeBakey VA Med Ctr, Houston Ctr Qual Care & Utilizat Studies, Houston, TX USA
[5] Washington Univ, Sch Med, Div Cardiol, St Louis, MO USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2010年 / 105卷 / 03期
基金
美国国家卫生研究院;
关键词
INVESTIGATION GROUP TRIAL; DIASTOLIC DYSFUNCTION; VASCULAR FUNCTION; SYSTOLIC FUNCTION; MORTALITY; IMPACT; DIGITALIS; PATHOGENESIS; MORBIDITY; STIFFNESS;
D O I
10.1016/j.amjcard.2009.09.041
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure (HF) with preserved left ventricular ejection fraction (LVEF) and diabetes commonly coexist, but the impact of diabetes on HF outcomes in patients with HF and preserved LVEF has not been well studied. We assessed the risk of HF death or hospitalization for worsening HF associated with diabetes by studying 987 patients with HF and preserved LVEF enrolled in the Digitalis Investigation Group (DIG) ancillary study. Diabetics (n = 285, 28.9%) were younger, had a larger body mass index, faster heart rate, and higher pulse pressure than nondiabetics. Diabetics were also more likely to be women, have a history of hypertension, ischemic cause for HF, and were more likely to be treated with diuretics. During the mean follow-up of 37 months, 88 (30.9%) diabetics and 133 (19.0%) nondiabetics developed the primary outcome of HF hospitalization or HF death. After adjustments for baseline differences, diabetes was associated with a 68% increased risk of HF hospitalization or HF death (adjusted hazard ratio 1.68, 95% confidence interval 1.26 to 2.25, p <0.001). In conclusion, in patients with HF and preserved LVEF, diabetes is associated with significantly increased risk of developing adverse HF outcomes. (C) 2010 Elsevier Inc. All rights reserved. (Am J Cardiol 2010;105:373-377)
引用
收藏
页码:373 / 377
页数:5
相关论文
共 50 条
  • [21] CHANGES IN LEFT VENTRICULAR EJECTION FRACTION AND OUTCOMES AMONG OUTPATIENTS WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
    Kalogeropoulos, Andreas P.
    Kim, Samuel
    Rawal, Sahil
    Tangutoori, Rasika
    Jadonath, Arvin
    Georgiopoulou, Vasiliki
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 679 - 679
  • [22] Comparison of Beta-Blocker Effectiveness in Heart Failure Patients With Preserved Ejection Fraction Versus Those With Reduced Ejection Fraction
    El-Refai, Mostafa
    Peterson, Edward L.
    Wells, Karen
    Swadia, Tanmay
    Sabbah, Hani N.
    Spertus, John A.
    Williams, L. Keoki
    Lanfear, David E.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (02) : 73 - 79
  • [23] Effect of diabetes mellitus on the development of left ventricular contractile dysfunction in women with heart failure and preserved ejection fraction
    Shi, Ke
    Yang, Meng-Xi
    Huang, Shan
    Yan, Wei-Feng
    Qian, Wen-Lei
    Li, Yuan
    Guo, Ying-Kun
    Yang, Zhi-Gang
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [24] Effect of diabetes mellitus on the development of left ventricular contractile dysfunction in women with heart failure and preserved ejection fraction
    Ke Shi
    Meng-Xi Yang
    Shan Huang
    Wei-Feng Yan
    Wen-Lei Qian
    Yuan Li
    Ying-Kun Guo
    Zhi-Gang Yang
    Cardiovascular Diabetology, 20
  • [25] Comparison of Mortality and Morbidity in Patients With Atrial Fibrillation and Heart Failure With Preserved Versus Decreased Left Ventricular Ejection Fraction
    Badheka, Apurva O.
    Rathod, Ankit
    Kizilbash, Mohammad A.
    Bhardwaj, Aditya
    Ali, Omaima
    Afonso, Luis
    Jacob, Sony
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (09): : 1283 - 1288
  • [26] Comparison of Effects of Statin Use on Mortality in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction
    Lee, Ming-Sum
    Duan, Lewei
    Clare, Ryan
    Hekimian, Avetis
    Spencer, Hillard
    Chen, Wansu
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (03): : 405 - 412
  • [27] Effects of Exercise on Left Ventricular Systolic and Diastolic Properties in Patients With Heart Failure and a Preserved Ejection Fraction Versus Heart Failure and a Reduced Ejection Fraction
    Zile, Michael R.
    Kjellstrom, Barbro
    Bennett, Tom
    Cho, Yong
    Baicu, Catalin F.
    Aaron, Mark F.
    Abraham, William T.
    Bourge, Robert C.
    Kueffer, Fred J.
    CIRCULATION-HEART FAILURE, 2013, 6 (03) : 508 - +
  • [28] Heart failure with preserved left ventricular ejection fraction (HFpEF)
    Maeder, Micha T.
    Rickli, Hans
    Scheler, Eva
    Ammann, Peter
    Buser, Marc
    THERAPEUTISCHE UMSCHAU, 2024, 81 (02) : 31 - 40
  • [29] Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction
    Mohammed, Selma F.
    Mirzoyev, Sultan A.
    Edwards, William D.
    Dogan, Ahmet
    Grogan, Donna R.
    Dunlay, Shannon M.
    Roger, Veronique L.
    Gertz, Morie A.
    Dispenzieri, Angela
    Zeldenrust, Steven R.
    Redfield, Margaret M.
    JACC-HEART FAILURE, 2014, 2 (02) : 113 - 122
  • [30] Pathological Insights to Heart Failure with Preserved Ejection Fraction-a Comparison of Patients With and Without Diabetes
    Gulsin, G. S.
    Kanagala, P.
    Chan, D. C. S.
    Cheng, A. S. H.
    Athithan, L.
    Graham-Brown, M. P. M.
    Singh, A.
    Khunti, K.
    Davies, M. J.
    Arnold, J. R.
    Squire, I. B.
    Ng, L. L.
    McCann, Gerry P. G. P.
    CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (02) : 264 - 264